Author

V. Chang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

K. E. Mahoney· 2 shared S. A. Malaker· 2 shared A. Artuyants· 1 shared A. Cioce· 1 shared A. Ni Cheallaigh· 1 shared B. Jacob· 1 shared B. Schumann· 1 shared C. Blenkiron· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

K. E. Mahoney

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Xylosyltransferase Bump-and-hole Engineering to Chemically Manipulate Proteoglycans in Mammalian Cells

Z. Li, L. Di Vagno, H. Chawla, A. Ni Cheallaigh, M. Critcher, D. Sammon, D. C. Briggs, N. Chung, V. Chang, K. E. Mahoney, A. Cioce, L. D. Murphy, Y.-H. Chen, Y. Narimatsu, R. L. Miller, , B. Schumann

This paper develops a chemical genetic strategy to manipulate proteoglycan glycan attachment sites in mammalian cells using modified xylosyltransferases.

bioRxiv · Dec 20, 2023 · PreprintBiochemistry

Optimized mucin-selective enrichment strategy to probe the mucinome

K. E. Mahoney, V. Chang, T. M. Lucas, K. Maruszko, S. A. Malaker

The paper optimizes a mucin-selective enrichment strategy to improve throughput, reduce sample input, and enhance glycopeptide signal for mucinome analysis.

bioRxiv · Dec 18, 2023 · PreprintBiochemistry

Investigating the Consistency of Extracellular Vesicle Production from Breast Cancer Subtypes Using CELLine Adherent Bioreactors

C. L. Hisey, A. Artuyants, G. Guo, V. Chang, G. Reshef, M. Middleditch, B. Jacob, L. W. Chamley, C. Blenkiron

This study shows that CELLine AD 1000 bioreactors can consistently produce EVs from multiple breast cancer subtypes, with stable core protein content over time.

Journal of Extracellular Biology · Sep 22, 2022Peer-reviewedCancer Biology